Samsara Inc vs Health Care Select Sector SPDR Fund — how do they compare? Samsara Inc trades at $40.17 (market cap $23.49B), while Health Care Select Sector SPDR Fund trades at $167.58. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Samsara Inc nearer its low. Which is the better fit depends on your goals.
| IOT | XLV | |
|---|---|---|
Market Cap | $23.49B | — |
Sector | Technology | — |
52-Week High | $45.22 | $168.44 |
52-Week Low | $24.25 | $131.16 |
Enterprise Value | $22.76B | — |
Signals from Pluang's Aura AI — not financial advice
Samsara (IOT) trades at $40.88, up 6.96% in the last session, with a bullish technical signal from moving averages. The company reported revenue of $1.25B in 2025 but a net loss of $154.91M, though it has beaten EPS estimates for three consecutive quarters. Analyst sentiment is strongly positive, with 14 of 18 analysts rating it a Buy and a consensus price target of $44.50. Recent news highlights institutional buying and the company's focus on AI-driven growth.
The outlook is optimistic due to strong analyst support and consistent earnings beats, but risks include high valuation multiples and ongoing profitability challenges. Investors should weigh the growth potential in AI and connected operations against the current negative net income and elevated P/E ratio of 398.6.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Samsara provides a connected operations cloud that uses IoT data to help businesses improve efficiency and safety. Its platform offers real-time visibility for fleet management, equipment monitoring, and industrial sites.
Read more on IOT →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →